Accessibility
EasyRead Text Version
Showing 1 to 2 of 2 Results
Roke Y. et al. (2012)
Bone mineral density in male adolescents with autism spectrum disorders and disruptive behavior disorder with or without antipsychotic treatment.
European Journal of Endocrinology
167(6), pp. 855-863.
Read Abstract (New Window)
Risk of hyperprolactinemia and sexual side effects in males 10-20 years old diagnosed with autism spectrum disorders or disruptive behavior disorder and treated with risperidone.
Journal of Child and Adolescent Psychopharmacology
22(6), pp. 432-439.
Publications | Publications Database | Search Publications
Rate This Page
Poor | Satisfactory | Good | Excellent
Print This Page / view All
Back to top
Your Rating: